comprehensive -WSS

comprehensive

author：comprehensive 2025-09-29 21:13:16 - browse：6

Photo illustration of a checkbook wrapped with lock and chain – hospital and investment coverage from STAT — Alex Hogan/STAT

Hospitals once dove headfirst into venture capital with splashy headlines and attention-grabbing numbers. Now, in an era of flattened margins and exceedingly uncertain returns, many health systems are quietly pulling back.

NewYork-Presbyterian’s venture firm, once managing roughly $40 million in assets, was essentially dissolved, two former employees said, with leaders punting it from the system’s strategy division to innovation, then from innovation to the investment office — a spokesperson described it as being “integrated” into the broader strategy. PitchBook data show no investments after 2020.

Advocate Health Enterprises, meanwhile, the venture firm of a 67-hospital system based in Charlotte, N.C., has lost at least six employees within the past year, including its president, from a staff that once included about a dozen people.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： JPM: CVS says Medicare Advantage patients are impacting profits

WSS

ActiGraph execs on goal of drug approvals with digital endpoints

Hilary may become 1st tropical storm to make landfall in California in 84 years

Clinical trials must include more disabled people

Congress must give Medicare recipients genetic counseling access

A single drug, study failures leave Anavex with nothing but cash

Feng Zhang CRISPR delivery startup lays off quarter of staff

focus

comprehensive

knowledge

Heart attack and stroke risk calculators need revising

Chronically ill young patients struggle to find fertility info

Dobbs anniversary: the lost opportunity of abortion as health care

Ahead of JPM, here's who's profiting most in health care

The cancer drug shortage isn’t new — and neither are the solutions

3 trends to watch in health tech's hiring outlook for 2024

Trump demands the U.S. pay no more for drugs than other countries … again

As Maui death toll rises, number of missing remains unclear

Alkermes shareholders re

UCB departs biotech trade group BIO

entertainment

Hilary expected to bring catastrophic, life

The biotech scorecard for Q1: 17 stock

ProMED sees offers of support, but its future remains unclear

Majority of Americans think Trump's Ga. election interference case is serious: POLL

Listen: Racing for gene therapy & a pioneering approval

UCB departs biotech trade group BIO

entertainment

hotspot

hotspot

entertainment